Document:

exv4w2

Exhibit 4.2

NEITHER THIS WARRANT NOR THE SHARES OF STOCK ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES LAWS. THEY HAVE
BEEN ACQUIRED SOLELY FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR
DISTRIBUTION THEREOF. NO SALE, TRANSFER OR OTHER DISPOSITION OF THIS WARRANT OR SAID SHARES MAY BE
EFFECTED WITHOUT (i) AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO, (ii) AN OPINION OF
COUNSEL SATISFACTORY IN FORM AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED
UNDER THE ACT OR ANY APPLICABLE STATE SECURITIES LAWS, OR (iii) RECEIPT OF A NO-ACTION LETTER FROM
THE SECURITIES AND EXCHANGE COMMISSION TO THE EFFECT THAT REGISTRATION UNDER THE ACT IS NOT
REQUIRED.

Date: September 3, 2009

COMMON STOCK WARRANT

OF

PVF CAPITAL CORP.

INCORPORATED UNDER THE LAWS OF THE STATE OF OHIO

THIS CERTIFIES THAT, for value received, ALESCO PREFERRED FUNDING IV, LTD. (the “Investor”) is
entitled to subscribe for and purchase shares (the “Shares”) of the fully paid and nonassessable
Common Stock of PVF CAPITAL CORP., an Ohio corporation (the “Company”), subject to the provisions
and upon the terms and conditions hereinafter set forth. As used herein, the term “Common Stock”
shall mean the Company’s duly authorized Common Stock, and any stock into or for which such Common
Stock may hereafter be exchanged pursuant to the Articles of Incorporation of the Company as from
time to time amended as provided by law and in such Articles, and the term “Grant Date” shall mean
the date set forth above.

This Warrant is issued in connection with the Exchange Agreement of even date herewith executed by
and among the Investor, Cohen & Company Financial Management, LLC, and the Company (the “Exchange
Agreement”).

	 	1.	 	TERM. Subject to the terms hereof, the purchase right represented by this
Warrant is exercisable, in whole, at any time from and after the Grant Date and at or
prior to 11:59 p.m. Eastern Standard Time on the date two (2) years following the Grant
Date. Notwithstanding the foregoing, in the event that the Company does not execute a
Capital II Agreement (as defined below) within one (1) year of the Grant Date, this
Warrant shall terminate and be of no effect. The number of Shares, type of security and
Exercise Price (as that term is defined in Section 2 hereof) are subject to adjustment as
provided herein, and all references to

 

 

	 	 	 	“Exercise Price” herein shall be deemed to include any such adjustment or series of
adjustments. Terms used herein and not otherwise defined shall have the meaning as set
forth in the Exchange Agreement.
	 
	 	2.	 	NUMBER OF SHARES. Subject to the terms and conditions hereinafter set forth,
in the event of a Capital II Agreement (as defined below), the Investor is entitled, upon
surrender of this Warrant, to purchase from the Company, shares of the Company’s stock in
an amount equal to the lesser of (i) the Allowable Number (as defined below) or (ii) the
maximum number of shares of the Company’s common stock then issued and outstanding such
that the Investor, upon its exercise of this Warrant, shall own 9.9% of the Company’s
common stock then issued and outstanding; provided, however, that the
maximum number of shares that can be purchased shall not exceed the
Allowable Number, and provided further that in the event the
Investor receives comfort from the Office of Thrift Supervision (“OTS”) that allows it to
rebut the presumption that its holdings of the Company’s common stock constitute control
of the Company for the purpose of the applicable OTS regulations, clause (ii) shall have
no effect. The purchase price for the shares of the Company’s common stock purchased
pursuant to this Warrant shall be at a purchase price equal to the Conversion Price (as
defined below) (“Exercise Price”). The “Capital II Agreement” shall be the written
agreement, if any, executed by the Company within one (1) year of the Grant Date, in
regard to the Company’s purchase of capital securities of PVF Capital Trust II, which
provides for the exchange of the Company’s shares of common stock for capital securities
of PVF Capital Trust II. The “Conversion Price” shall be equal to the price, if any,
utilized in the Capital II Agreement to determine the number of shares of the common stock
of the Company to be exchanged for capital securities of PVF Capital Trust II pursuant to
the Capital II Agreement exclusive of any warrants, warrant shares or
warrant prices. By way of example for illustrative purposes, if the
Capital II Agreement provided for terms identical to those provided
in this Agreement, then the Conversion Price would be the average
daily closing price of the Company's common stock for the twenty (20)
business days prior to the date of the Capital II Agreement. The
“Allowable Number” shall be the lesser of (i) 9.9% of the Company’s common stock exchanged
at the Conversion Price pursuant to the Capital II Agreement or (ii) 1,546,991 less the
sum of 769,608 plus the number of shares issued pursuant to Section 2.1(b) of the Exchange
Agreement.
	 
	 	3.	 	METHOD OF EXERCISE. The purchase right represented by this Warrant may be
exercised by the Investor, in whole, by the surrender of this Warrant (with the notice of
exercise form attached hereto as Exhibit A duly executed) at the principal office
of the Company accompanied by payment to the Company, by certified check, or wire transfer
payable to the Company, in an amount equal to the then applicable Exercise Price per share
multiplied by the number of Shares then being purchased. Thereupon, the Investor, as the
holder of this Warrant, shall be entitled to receive from the Company a stock certificate
representing the number of Shares so purchased which shall be delivered to the Investor as
soon as possible and in any event within thirty (30) days of receipt of such notice,
surrendered Warrant and proper payment. The Investor shall be deemed to have become the
holder(s) of record of, and shall be treated for all purposes as the

 

 

	 	 	 	record holder(s) of, the Shares represented thereby (and such Shares shall be deemed to
have been issued) immediately prior to the close of business on the date or dates upon
which this Warrant is exercised.
	 
	 	4.	 	STOCK FULLY PAID: RESERVATION OF SHARES. The Shares that may be issued upon
the exercise of the rights represented by this Warrant will, upon issuance, be fully paid
and non assessable, and free from all taxes, liens and charges with respect to the issue
thereof. During the period within which the rights represented by this Warrant may be
exercised, the Company will at all times have authorized, subject to shareholder approval,
if required by applicable law, and reserved for the purpose of issuance upon exercise of
the purchase rights evidenced by this Warrant, a sufficient number of Shares to provide
for the exercise of the right represented by this Warrant.
	 
	 	5.	 	ADJUSTMENT OF WARRANT PRICE AND NUMBER OF SHARES. After execution of the
Capital II Agreement, the number and kind of securities purchasable upon the exercise of
this Warrant and the Exercise Price shall be subject to adjustment from time to time upon
the occurrence of certain events, as follows:

	 	a.	 	Reclassification or Merger. If at any time while this
Warrant remains outstanding and unexpired, in case of any reclassification, change
or conversion of securities of the class issuable upon exercise of this Warrant
(other than a change in par value, or from par value to no par value, or from no
par value to par value, or as a result of a subdivision or combination), or in
case of any merger of the Company with or into another corporation (other than a
merger with another corporation in which the Company is a continuing corporation
and which does not result in any reclassification or change of outstanding
securities issuable upon exercise of this Warrant), or in case of any sale of all
or substantially all of the assets of the Company, the Company, or such successor
or purchasing corporation, as the case may be, shall execute a new Warrant (in
form and substance reasonably satisfactory to the Investor) providing that the
Investor shall have the right to exercise such new Warrant and upon such exercise
to receive, in lieu of each share of Common Stock theretofore issuable upon
exercise of this Warrant, the kind and amount of shares of stock, other
securities, money and property receivable upon such reclassification, change or
merger by a holder of one share of Common Stock. Such new Warrant shall provide
for adjustments that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Paragraph 5. The provisions of this subparagraph
(a) shall similarly apply to successive reclassification, changes, mergers and
transfers.
	 
	 	b.	 	Subdivisions or Combination of Shares. If the Company at any
time while this Warrant remains outstanding and unexpired shall subdivide or
combine its Common Stock, the number of Shares issuable upon exercise

 

 

	 	 	 	hereof shall be proportionally adjusted and the Exchange Price shall be adjusted so
that the aggregate exercise price of this Warrant shall at all time remains equal
	 
	 	c.	 	Common Stock Dividends. If the Company at any time while
this Warrant is outstanding and unexpired shall pay a dividend payable in shares
of Common Stock (except any distribution specifically provided for in the
foregoing subparagraphs (a) and (b)), then the Exercise Price shall be adjusted,
from and after the date of determination of shareholders entitled to receive such
dividend or distribution, to that price determined by multiplying the Exercise
Price in effect immediately prior to such date of determination by a fraction (i)
the numerator of which shall be the total number of shares of Common Stock
outstanding immediately prior to such dividend or distribution, and (ii) the
denominator of which shall be the total number of shares of Common Stock
outstanding immediately after such dividend or distribution and the number of
Shares subject to this Warrant shall be proportionately adjusted.
	 
	 	d.	 	No Impairment. The Company will not, by amendment of its
Articles of Incorporation or through any reorganization, recapitalization,
transfer of assets, consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance or
performance of any of the terms to be observed or performed hereunder by the
Company, but will at all times in good faith assist in the carrying out of all the
provisions of this Paragraph 5 and in the taking of all such action as maybe
necessary or appropriate in order to protect the rights of the Investor against
impairment.

	 	6.	 	NOTICE OF ADJUSTMENTS. Whenever the Exercise Price shall be adjusted
pursuant to the provisions hereof, the Company shall within thirty (30) days of such
adjustment deliver a certificate signed by its chief financial officer to the Investor
setting forth, in reasonable detail, the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated, and the Exercise Price
after giving effect to such adjustment.
	 
	 	7.	 	FRACTIONAL SHARES. No fractional Shares of Common Stock will be issued in
connection with any exercise hereunder, but in lieu of such fractional Shares the Company
shall make a cash payment equal to the excess of the average daily closing price of the
Company’s common stock for the twenty (20) business days prior to the exercise date for
such fractional shares above the Warrant Price for such fractional share.
	 
	 	8.	 	TRANSFERS AND EXCHANGES. This Warrant shall be transferable by the Investor
provided that the Investor in connection with such transfer delivers to the

 

 

	 	 	 	Company an opinion of counsel, in form and substance satisfactory to the Company, that
registration is not required under the Securities Act of 1933, as amended, or any
applicable state securities laws.

	 	9.	 	RIGHTS AS STOCKHOLDERS. The Investor, as holder of this Warrant, shall not be
entitled to vote or receive dividends or be deemed the holder of Common Stock, or any
other securities of the Company which may at any time be issuable on the exercise thereof
for any purpose, nor shall anything contained herein be construed to confer upon the
Investor, any of the rights of a stockholder of the Company or any right to vote for the
election of directors or upon any matter submitted to stockholders at any meeting thereof,
or to receive notice of meetings, or to receive dividends or subscription rights or
otherwise until this Warrant shall have been exercised and the Shares purchasable upon the
exercise hereof shall have become deliverable, as provided herein.
	 
	 	10.	 	REPRESENTATIONS AND WARRANTIES OF THE COMPANY. This Warrant is issued and
delivered on the basis of the following:

	 	a.	 	This Warrant has been duly authorized and executed by the Company
and when delivered will be the valid and binding obligation of the Company
enforceable in accordance with its terms;
	 
	 	b.	 	The Shares have been duly authorized by the Company and when issued
in accordance with the terms hereof, will be validly issued, fully paid and
nonassessable;
	 
	 	c.	 	The rights, preferences, privileges and restrictions granted to or
imposed upon the Shares and the Investor are as set forth in the Company’s
Articles of Incorporation, as amended;
	 
	 	d.	 	The execution and delivery of this Warrant are not, and the
issuance of the Shares upon exercise of this Warrant in accordance with the terms
hereof will not be, inconsistent with the Company’s Articles of Incorporation or
by-laws, do not and will not contravene any law, governmental rule or regulation,
judgment or order applicable to the Company, and do not and will not contravene
any provision of, or constitute a default under, any indenture, mortgage,
contract or other instrument of which the Company is a party or by which it is
bound or require the consent or approval of, the giving of notice to, the
registration with or the taking of any action in respect of or by, any federal
state or local government authority or agency or other person.

	 	12.	 	REPRESENTATIONS AND WARRANTIES OF INVESTOR. The Investor hereby represents
and warrants that:

 

 

	 	a.	 	Purchase Entirely for Own Account. This Warrant is issued
to the Investor in reliance upon Investor’s
representation to the Company, which by its acknowledgment of this Warrant
Investor hereby confirms, that the Warrant and the Common Stock issuable upon
exercise of the Warrant (collectively, the “Securities”) will be acquired for
investment for the Investor’s own account, not as a nominee or agent, and not
with a view to the resale or distribution of any part thereof, and that the
Investor has no present intention of selling, granting any participation in, or
otherwise distributing the same. By acknowledging this Warrant, it does not have
any contract, undertaking, agreement, or arrangement with any person to sell,
transfer, or grant participations to such person or to any third person, with
respect to any of the Securities. It has full power and authority to acknowledge
this Warrant.
	 
	 	b.	 	Disclosure of Information. It has had an opportunity to
ask questions and receive answers from the Company regarding the terms and
conditions of the offering of the Warrant.
	 
	 	c.	 	Investment Experience. The Investor acknowledges that it
can bear the economic risk of its investment, and has not been organized solely
for the purpose of acquiring the Warrant.
	 
	 	d.	 	Accredited Investor. The Investor is an “accredited
investor” within the meaning of SEC Rule 501 of Regulation D, as presently in
effect.
	 
	 	e.	 	Restricted Securities. It understands that the Securities
it is purchasing are characterized as “restricted securities” under the federal
securities laws inasmuch as they are being acquired from the Company in a
transaction not involving a public offering and that under such laws and
applicable regulations such securities may be resold without registration under
the Act only in certain limited circumstances. In this connection, the Investor
represents that it is familiar with SEC Rule 144, as presently in effect, and
understands the resale limitations imposed thereby and by the Act.
	 
	 	f.	 	Legends. It is understood that the certificates evidencing
the Securities may bear one or all of the following legends:

	 	i.	 	“THE SHARES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THESE
SHARES HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO
DISTRIBUTION OR RESALE, AND MAY NOT BE MORTGAGED, PLEDGED,
HYPOTHECATED, OR OTHERWISE TRANSFERRED WITHOUT AN

 

 

	 	 	 	EFFECTIVE REGISTRATION STATEMENT FOR SUCH SHARES UNDER THE SECURITIES ACT
OF 1933 OR AN OPINION OF COUNSEL FOR THE CORPORATION THAT REGISTRATION IS
NOT REQUIRED UNDER SUCH ACT.”

	 	13.	 	MODIFICATION AND WAIVER. This Warrant and any provision hereof may be
changed, waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of the same is sought.
	 
	 	14.	 	NOTICES. All notices, demands or requests provided for or permitted to be
given pursuant to this Agreement must be in writing and shall be delivered or sent, with
the copies indicated, by personal delivery, telecopy (with confirmation and additional
copy sent by overnight delivery service) or overnight delivery service (by a reputable
international carrier) to the parties as follows (or at such other address as a party may
specify by notice given pursuant to this Section);

	 	 	 	 	 
	 

	 	To Investor:
	 	ALESCO PREFERRED FUNDING IV, LTD.
	 

	 	 	 	c/o Cohen & Company Financial Management, LLC
	 

	 	 	 	2929 Arch Street, 17th Floor
	 

	 	 	 	Philadelphia, PA 19104-2870
	 

	 	 	 	Attn: Samuel Hillier, Director
	 

	 	 	 	Fax: (215) 701-8282
	 

	 	 	 	Email: shillier@cohenandcompany.com
	 
	 	 	 	 
	 

	 	With a Copy to:
	 	DECHERT LLP
	 

	 	 	 	2929 Arch Street
	 

	 	 	 	Philadelphia, PA 19104
	 

	 	 	 	Attn: Ralph R. Mazzeo, Esq.
	 

	 	 	 	Fax: (215) 994-2222
	 

	 	 	 	Email: ralph.mazzeo@dechert.com
	 
	 	 	 	 
	 

	 	To Company:
	 	PVF CAPITAL CORP.
	 

	 	 	 	30000 Aurora Road
	 

	 	 	 	Solon, Ohio 44139
	 

	 	 	 	Attn: Chief Executive Officer
	 

	 	 	 	Fax: (440) 914-3916

 

 

	 	 	 	 	 
	 

	 	With a copy to:
	 	Krugliak, Wilkins, Griffiths
	 

	 	 	 	& Dougherty Co., L.P.A.
	 

	 	 	 	4775 Munson St. N.W.
	 

	 	 	 	P.O. Box 36963
	 

	 	 	 	Canton, Ohio 44735-6963
	 

	 	 	 	Attn: Randall C. Hunt,
	 

	 	 	 	Fax: (330) 497-4020
	 

	 	 	 	Email: rchunt@kwgd.com

All notices shall be deemed given and received one business day after their delivery to the
addresses for the respective party(ies), with the copies indicated, as provided in this
Section 14.

	 	15.	 	BINDING EFFECT ON SUCCESSORS. The terms and provisions of this Warrant
shall be binding upon the Company and its respective successors and assigns and the
Investor. All of the obligations of the parties relating to the Common Stock issuable
upon the exercise of this Warrant shall survive the exercise and termination of this
Warrant and all of the covenants and agreements of each party relating thereto shall
inure to the benefit of the successors and assigns of the other. The Company will, at
the time of the exercise of this Warrant, in whole or in part, upon request of the
Investor but at the Company’s expense, acknowledge in writing its continuing obligation
to the Investor in respect of any rights (including, without limitation, any right to
registration of the shares of Registrable Securities) to which the Investor shall
continue to be entitled after such exercise in accordance with this Warrant; provided,
that the failure of the Investor to make any such request shall not affect the continuing
obligation of the Company to the Investor in respect of such rights.
	 
	 	16.	 	LOST WARRANTS OR STOCK CERTIFICATES. The Company covenants to the Investor
that upon receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction, or mutilation of this Warrant or any stock certificate and, in the case of
any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory
to the Company, or in the case of any such mutilation upon surrender and cancellation of
such Warrant or stock certificate, the Company will make and deliver a new Warrant or
stock certificate, or like tenor, in lieu of the lost, stolen, destroyed or mutilated
Warrant or stock certificate.
	 
	 	17.	 	DESCRIPTIVE HEADINGS. The descriptive headings of the several paragraphs
of this Warrant are inserted for convenience only and do not constitute a part of this
Warrant.

 

 

	 	18.	 	GOVERNING LAW. This Agreement and the interpretation of its terms shall be
governed by the laws of the State of New York, without application of conflicts of law
principles.
	 
	 	19.	 	CONFIDENTIALITY; NO PUBLIC DISCLOSURE. The terms and conditions of this
Warrant are confidential. Neither party shall make any public disclosure concerning the
terms and conditions of this Warrant without the prior written consent of the other
party, except as required by the rules and regulations of the Securities and Exchange
Commission, the Nasdaq National Market or any other applicable stock exchanges.
	 
	 	20.	 	ATTORNEYS FEES. Except as otherwise set forth in the Exchange Agreement,
the Company and Investor shall pay their respective attorneys’ fees and expenses for the
negotiation and preparation of this Warrant and the other agreements contemplated by this
Warrant.
	 
	 	21.	 	COUNTERPARTS. This Agreement may be executed and delivered in two or more
counterparts, each of which shall be deemed to be an original and all of which, taken
together, shall be deemed to be one agreement.

[Remainder of Page Intentionally Left Blank]

 

 

     The parties have executed this Warrant as of the date set forth above.

		
	 	 
	Investor:
	ALESCO PREFERRED FUNDING IV, LTD.
	 
	By: COHEN & COMPANY FINANCIAL
	 
	MANAGEMENT, LLC, solely in its
	 
	capacity as Manager

	 	 	 	 	 
	 	 	 
	 	By:  	/s/ Samuel Hillier
 	 
	 	 	Name:  	Samuel Hillier 	 
	 	 	Title:  	Director 	 
	 
	Company:             	PVF CAPITAL CORP.,

An Ohio corporation

 	 
	 	By:  	/s/ Marty E. Adams 	 
	 	 	Name:  	Marty E. Adams 	 
	 	 	Title:  	Interim CEO 	 

 

 

	 	 	 	 	 

EXHIBIT A

NOTICE OF EXERCISE

To: PVF CAPITAL CORP.

30000 Aurora Road

Solon, Ohio 44139

Attn:

	 	1.	 	The undersigned hereby elects to purchase _________ Shares of Common Stock of PVF
CAPITAL CORP. pursuant to the terms of the attached Warrant, and tenders herewith payment
of the purchase price of such Shares in full.
	 
	 	2.	 	Please issue a certificate or certificates representing said Shares in the name of the
undersigned or in such other name or names as are specified below:

	 	 	 	 	 
	Name:
	 	 	 	 
	 

	 	 

	 	 
	Address:
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 

	 	3.	 	The undersigned represents that the aforesaid Shares being acquired for the account of
the undersigned for investment and not with a view to, or for resale in connection with,
the distribution thereof and that the undersigned has no present intention of distributing
or reselling such Shares.

ALESCO PREFERRED FUNDING IV, LTD.

By: COHEN & COMPANY FINANCIAL

MANAGEMENT, LLC, solely in its

capacity as Manager

	 	 	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	Samuel Hillier 	 
	 	 	Title:  	Directorexv10w1

Exhibit 10.1

EXCHANGE AGREEMENT

     THIS EXCHANGE AGREEMENT (this “Agreement”), dated as of September 1, 2009, by and among ALESCO
PREFERRED FUNDING IV, LTD., a Cayman Islands exempted company (the “Alesco CDO”), COHEN & COMPANY
FINANCIAL MANAGEMENT, LLC (“Manager”), and PVF CAPITAL CORP., an Ohio bank holding company (the
“Company”).

RECITALS

     A. Reference is made to that certain Indenture (the “Indenture”), dated as of June 29, 2004,
by and between the Company and The Bank of New York Mellon Trust Company, National Association, a
national banking association (as successor to JPMorgan Chase Bank, National Association) (“BNYM”).

     B. Reference is made to that certain Trust Agreement (the “Trust Agreement”), dated as of July
23, 2004, by and among the Company, BNYM, BNY Mellon Trust of Delaware (as successor to Chase Bank
USA, National Association, the respective administrative trustees named therein and other parties
thereto.

     C. PVF Capital Trust I, a Delaware business trust (the “Trust”), is the holder of a Junior
Subordinated Note due 2034 in the original principal amount of $10,310,000 issued by the Company
pursuant to the Indenture.

     D. The Alesco CDO is the holder of Trust Preferred Securities due July 23, 2034 in the
original principal amount of $10,000,000 (the “TruPS”) issued by the Trust pursuant to the Trust
Agreement.

     E. On August 7, 2009, the Manager on behalf of and as Collateral Manager for the Alesco CDO,
and the Company executed a certain offer letter (the “Letter Agreement”), pursuant

 

 

to which the
Alesco CDO and the Company agreed that the Alesco CDO would exchange the
TruPS for the consideration set forth herein pursuant to the terms and conditions of this Agreement
(the “Exchange”).

AGREEMENT

     NOW, THEREFORE, in consideration of the mutual agreements and subject to the terms and
conditions herein set forth, the parties hereto agree as follows:

     1. Exchange of TruPS.

          Upon and subject to the terms and conditions contained in this Agreement, on the Closing Date
(as defined in Section 9.1), the Alesco CDO shall deliver the TruPS to the Company, free and clear
of all claims, liens and Encumbrances (as defined herein), and the Company shall transfer and
deliver to the Alesco CDO the consideration set forth in Section 2.1 of this Agreement.

     2. Consideration for the Exchange.

          2.1 Exchange Price.

          The consideration to be delivered to the Alesco CDO as set forth in Section 1 (the “Exchange
Price”) shall be:

	 	(a)	 	a cash payment of FIVE HUNDRED THOUSAND DOLLARS
($500,000.00);
	 
	 	(b)	 	a number of shares of the Company’s common
stock equal to $500,000.00 divided by the average daily closing price
of the Company’s common stock for the twenty (20) business days prior
to the date of this Agreement (“Common Stock”); and
	 
	 	(c)	 	a warrant, in the form attached hereto as
Exhibit A (the “Exhibit A Warrant”), to purchase the lesser of 769,608
shares of the 

2

 

	 	 	 	Company’s common stock or (ii) the maximum number of
shares of the Company’s common stock then issued and outstanding such
that the Alesco CDO, upon its exercise of the Exhibit A Warrant,
shall own 9.9% of the Company’s common stock then issued and
outstanding; provided, however, that the maximum number of shares
that can be purchased shall not exceed 769,608 shares, and provided
further that in the event the Alesco CDO receives comfort from the
Office of Thrift Supervision (“OTS”) that allows it to rebut the
presumption that its holdings of the Company’s common stock
constitute control of the Company for the purpose of the applicable
OTS regulations, clause (ii) shall have no effect. The Exhibit A
Warrant shall be exercisable within two (2) years of the Closing Date
and shall provide for purchase of the shares at a strike price equal
to the lesser of (i) $4.00 per share or (ii) in the event that the
Company consummates a public offering, other than pursuant to an
employee benefit plan of the Company, the public offering price for
shares of the Company’s common stock in such offering or in the event
that the Company consummates a private placement of shares of its
common stock in exchange exclusively for cash consideration pursuant
to Regulation D, the Regulation D private placement offering price
for shares of the Company’s common stock or (iii) the Conversion
Price (as defined in Section 2.1(d) below).

3

 

	 	(d)	 	a warrant, in the form attached hereto as
Exhibit B (the “Exhibit B Warrant”) to purchase the lesser of (i) the
Allowable Number (as defined below) of shares of the Company’s common
stock or (ii) the maximum number of shares of the Company’s common
stock
then issued and outstanding such that the Alesco CDO, upon its
exercise of the Exhibit B warrant, shall own 9.9% of the Company’s
common stock then issued and outstanding; provided, however, that the
maximum number of shares that can be purchased shall not exceed the
Allowable Number, and provided further that in the event the Alesco
CDO receives comfort from OTS that allows it to rebut the presumption
that its holdings of the Company’s common stock constitute control of
the Company for the purpose of the applicable OTS regulations, clause
(ii) shall have no effect. The Exhibit B Warrant shall be
exercisable within two years of the Closing Date only in the event
that the Capital II Agreement (as defined below) is consummated by
the Company, and shall provide for the purchase of the Company’s
common stock at the Conversion Price (as defined below). The
“Capital II Agreement” shall be the written agreement, if any,
executed by the Company within one (1) year of the Closing Date, in
regard to the Company’s purchase of capital securities of PVF Capital
Trust II, which provides for the exchange of the Company’s shares of
common stock for capital securities of PVF Capital Trust II. The
“Conversion Price” shall be equal to the price, if any, utilized in

4

 

	 	 	 	the Capital II Agreement to determine the number of shares of the
common stock of the Company to be exchanged for capital securities of
PVF Capital Trust II exclusive of any warrants, warrant shares or
warrant prices. By way of example for illustrative purposes, if the
Capital II Agreement provided for
terms identical to those provided in this Agreement, then the
Conversion Price would be the average daily closing price of the
Company’s common stock for the twenty (20) business days prior to the
date of the Capital II Agreement. The “Allowable Number” shall be the
lesser of (i) 9.9% of the Company’s common stock exchanged at the
Conversion Price pursuant to the Capital II Agreement exclusive of
any warrants or warrant shares or (ii) 1,546,991 less the sum of
769,608 plus the number of shares issued pursuant to Section 2.1(b)
above.

          2.2 Payment of Exchange Price.

          The Company shall deliver the cash portion of the Exchange Price by wire transfer of
immediately available funds to the Alesco CDO on the Closing Date pursuant to the wire instructions
set forth on Exhibit C.

          2.3 Representations and Warranties of the Alesco CDO regarding the Common Stock.

          The Alesco CDO represents and warrants to the Company as follows:

	 	(a)	 	(i) The Alesco CDO is familiar with the nature
of and risks involved in an investment in the Common Stock, (ii) is
financially capable of bearing the economic risk of this investment,
and (iii) 

5

 

	 	 	 	has carefully considered and evaluated the risks and
advantages of receiving the Common Stock.
	 
	 	(b)	 	The Alesco CDO understands that (i) the Common
Stock has not been registered under the Securities Act of 1933, as
amended (hereinafter referred to as the “1933 Act”) or any state
securities laws, (ii) the Common Stock is being acquired for investment
and
agrees and represents that it will not sell or distribute the Common
Stock or any portion thereof without compliance with all applicable
securities laws.
	 
	 	(c)	 	The Alesco CDO is fully aware that the Common
Stock is being issued and sold in reliance upon an exemption provided
for by the 1933 Act and the applicable state securities laws, on the
basis that no public offering is involved, and that the representations
set forth in this Agreement are being relied upon by the Company and
are essential to the availability of such exemption.
	 
	 	(d)	 	The Alesco CDO acknowledges and understands
that the certificate evidencing its ownership of the Common Stock will
be imprinted with a legend substantially in the following form:
	 
	 	 	 	THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933. THESE SHARES HAVE BEEN ACQUIRED
FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY
NOT BE MORTGAGED, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED
WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SHARES UNDER THE
SECURITIES ACT OF 1933 OR AN OPINION OF COUNSEL FOR THE CORPORATION
THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT.

6

 

	 	(e)	 	The Alesco CDO is acquiring the Common Stock
for its own account.
	 
	 	(f)	 	The offer and purchase of the Common Stock was
initiated in a private, negotiated transaction between the Alesco CDO
and Company, and no general solicitation was utilized by the Company.
	 
	 	(g)	 	The Alesco CDO is a resident, for tax and other
purposes, of the Cayman Islands.
	 
	 	(h)	 	The Alesco CDO is an Accredited Investor (as
such term is defined in Rule 501 promulgated under the 1933 Act) and
the Alesco CDO is an Accredited Investor due to his meeting the
following class of Accredited Investor:
	 
	 	 	 	An organization described in Section 501(c)(3) of the Internal
Revenue Code of 1986, as amended; or a corporation, Massachusetts or
similar business trust, or partnership, not formed for the specific
purpose of acquiring the Common Stock, with total assets in excess of
$5,000,000.

     3. Representations and Warranties of the Alesco CDO.

     The Alesco CDO makes the representations and warranties contained in Sections 3.1 through 3.8
to the Company intending that the Company rely on each of such representations and warranties in
order to induce the Company to enter into and complete the transaction contemplated by this
Agreement. The representations and warranties set forth in this Article 3 shall survive the
consummation of the transaction contemplated by this Agreement until the expiration of one (1) year
from the Closing Date, provided that in the case of fraud, the

7

 

representations and warranties shall
survive the consummation of such transaction without any time limit. Where reference is made to
the knowledge of the Alesco CDO, such knowledge means and includes the actual knowledge of any of
the directors or officers of the Alesco CDO.

          3.1 Execution and Validity (the Alesco CDO).

          The Alesco CDO has the full right, power and authority to enter into, and the ability to
perform its obligations under this Agreement and all other agreements and instruments contemplated
by this Agreement. This Agreement has been duly executed and delivered by the
Alesco CDO and is, and the other agreements and instruments to be executed and delivered by
the Alesco CDO will be, when executed and delivered by it, legal, valid and binding agreements of
the Alesco CDO, enforceable in accordance with their respective terms.

          3.2 Execution and Validity (Manager).

          The Manager has the full right, power and authority to enter into this Agreement and all other
agreements and instruments contemplated by this Agreement on behalf of the Alesco CDO. This
Agreement has been duly executed and delivered by the Manager, on behalf of Alesco CDO and is, and
all other agreements and instruments to be executed and delivered by the Manager will be, when
executed and delivered by the Manager, legal, valid and binding agreements of the Alesco CDO,
enforceable in accordance with their respective terms.

          3.3 Organization and Qualification.

          The Alesco CDO (a) is duly organized, validly existing and in good standing under the laws of
its jurisdiction of formation, and (b) has all the requisite power and authority to carry on its
businesses as such businesses are presently conducted.

          3.4 Absence of Encumbrances (the Alesco CDO).

          The Alesco CDO is the record and beneficial owner of the TruPS, free and clear of any liens,
pledges, claims, restrictions, agreements, charges and encumbrances of any kind

8

 

(“Encumbrances”)
and there are no pending or, to Alesco CDO’s knowledge, threatened claims or proceedings which
would impair or encumber any of the TruPS.

          3.5 Absence of Encumbrances (Manager).

          The Manager has no Encumbrances of any kind whatsoever with respect to any of the TruPS.

          3.6 Absence of Violations.

          Neither the execution nor delivery of this Agreement or of any of the other agreements and
instruments contemplated by this Agreement, nor the consummation of the
transaction contemplated by this Agreement or such other agreements and instruments will (a)
conflict with or result in the breach of any term or provision of, or constitute a default under,
or give any third party the right to accelerate any obligation under, any charter provision, bylaw,
contract, agreement indenture, deed of trust, instrument, order, law or regulation to which the
Alesco CDO is a party or by which the Alesco CDO, or any of its assets or properties are in any way
bound or obligated or (b) result in the creation of any Encumbrance upon any of the TruPS.

          3.7 Consents.

          (a) No consent, approval, order or authorization of, or registration, qualification,
designation, declaration or filing with, any governmental authority is required on the part of the
Alesco CDO in connection with the transaction contemplated by this Agreement; and (b) no consent,
approval, waiver or other action by any person or entity under any contract, instrument or other
document is required or necessary for the execution, delivery and performance of this Agreement by
the Alesco CDO, or the consummation by the Alesco CDO of the transaction contemplated by this
Agreement.

9

 

          3.8 Brokers.

          No agent, broker, investment banker or other person or entity acting on behalf of the Alesco
CDO or under its authority, is or will be entitled to any broker’s fee or finder’s fee or any other
commission or similar fee, directly or indirectly, in connection with the transaction contemplated
by this Agreement for which the Company or the Alesco CDO is or will become liable.

     4. Representations and Warranties of Company.

          The Company makes the representations and warranties contained in Sections 4.1 through 4.9 to
the Alesco CDO intending that the Alesco CDO rely on each of such representations and warranties in
order to induce the Alesco CDO to enter into and complete the transaction contemplated by this
Agreement. These representations and warranties shall survive
the consummation of the transaction contemplated by this Agreement until the expiration of one
(1) year from the Closing Date, provided that in cases of fraud these representations and
warranties shall survive the consummation of such transaction without any time limit. Where
reference is made to the knowledge of the Company, such knowledge means and includes the actual
knowledge of any of the directors or officers of the Company.

          4.1 Execution and Validity.

          The Company has the full right, power and authority to enter into, and the ability to perform
its obligations under this Agreement and all other agreements and instruments contemplated by this
Agreement. This Agreement has been duly executed and delivered by the Company and is, and the
other agreements and instruments to be executed and delivered by the Company will be, when executed
and delivered by it, legal, valid and binding agreements the Company, enforceable in accordance
with their respective terms.

10

 

          4.2 Organization and Qualification.

          The Company (a) is duly organized, validly existing and in good standing under the laws of its
jurisdiction of formation, and (b) has all the requisite power and authority to carry on its
businesses as such businesses are presently conducted.

          4.3 Absence of Encumbrances.

          The Common Stock has been duly authorized by all necessary corporate action. When issued and
sold against receipt of consideration thereof, the Common Stock will be validly issued by the
Company, fully paid, non-assessable, will not subject the holders thereof to personal liability and
will not be issued in violation of preemptive rights. The voting rights provided for in the terms
of the Common Stock are validly authorized and shall not be subject to restriction or limitation in
any respect except as set forth in the Company’s Articles of Incorporation or Ohio law. Any
subsequent common stock issued by the Company pursuant to Section 2.1(c) or Section 2.1(d) will be
validly issued by the Company, fully paid, non-
assessable, will not subject the holders thereof to personal liability and will not be issued
in violation of preemptive rights. The voting rights provided for in the terms of any common stock
issued by the Company pursuant to Section 2.1(c) or Section 2.1(d) will be validly authorized and
shall not be subject to restriction or limitation in any respect except as set forth in the
Company’s Articles of Incorporation or Ohio law.

          4.4 Absence of Violations.

          Neither the execution nor delivery of this Agreement or of any of the other agreements and
instruments contemplated by this Agreement, nor the consummation of the transaction contemplated by
this Agreement or such other agreements and instruments, will (a) conflict with or result in the
breach of any term or provision of, or constitute a default under, or give any third party the
right to accelerate any obligation under, any charter provision, bylaw,

11

 

contract, agreement,
indenture, deed of trust, instrument, order, law or regulation to which the Company is a party or
by which the Company or any of its assets or properties are in any way bound or obligated; or (b)
result in the creation of any Encumbrance upon any of the assets or properties of the Company.

          4.5 Consents.

          (a) No consent, approval, order or authorization of, or registration, qualification,
designation, declaration or filing with, any governmental authority is required on the part of the
Company in connection with the transaction contemplated by this Agreement; and (b) no consent,
approval, waiver or other action by any person or entity under any contract, instrument or other
document is required or necessary for the execution, delivery and performance of this Agreement by
the Company, or the consummation by the Company of the transaction contemplated by this Agreement.

          4.6 Litigation and Governmental Matters.

          There is no action, suit or proceeding that has been (a) filed and served, whether or not
purportedly on behalf of the Company, at law or in equity, or before or by any federal, state,
local or other governmental department, commission, board, bureau, agency or instrumentality,
domestic or foreign, which is pending; or (b) to the knowledge of the Company, (i) filed but not
served or (ii) threatened, against (including, but not limited to, counterclaims) Company which
involves the transaction contemplated by this Agreement or the possibility of any judgment or
liability which if determined adversely to the Company would result in a material adverse change in
the business, operations, affairs, properties or assets, or in the financial condition of the
Company; and the Company is not in default with respect to any final judgment, writ, injunction,
decree, rule or regulation of any court or any federal, state, local or

12

 

other governmental
department, commission, board, bureau, agency or instrumentality, domestic or foreign, which would
have a material adverse effect on the Company.

          4.7 Compliance.

          Neither the Company nor its business, nor the use, operation or maintenance of any of its
assets or properties, is in or constitutes a default under, or is in violation of or contravenes,
any applicable (including, without limitation, any tax, health, employment, customs or interstate
or international commerce) statute, law, ordinance, decree, order, rule or regulation of any
governmental authority, domestic or foreign, except where such default, violation or contravention
would not have a material adverse effect on the Company. The Company has not, nor has any entity
or individual acting on behalf of the Company made any payment of funds prohibited by law, and no
funds of the Company have been set aside to be used for any such payment. The Company has complied
with all applicable laws and regulations in connection with government contracts, if any, and, to
the knowledge of the Company, no person or entity has made any allegation that the Company has not
so complied.

          4.8 Brokers.

          No agent, broker, investment banker, or other person or entity acting on behalf of the Company
or under its authority, is or will be entitled to any broker’s fee or finder’s fee or any other
commission or similar fee, directly or indirectly, in connection with the transaction contemplated
by this Agreement for which the Alesco CDO will become liable.

          4.9 Securities Registration.

          Company represents and warrants that since September 1, 2008, it has on a timely basis filled
all forms, reports and documents required to be filed by it with the Securities and Exchange
Commission under the Securities Exchange Act of 1934, as amended, and such forms, reports and
documents filed by the Company did not at the time filed with the Securities and

13

 

Exchange
Commission (or if amended or superseded by a filing prior to the date of this Agreement, then on
the date of such filing) contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading.

     5. Covenants of the Alesco CDO.

          In addition to other obligations contained in this Agreement, between the date of this
Agreement and the Closing, unless specifically waived, in writing, by the Company, the Alesco CDO
shall:

          5.1 Cooperation.

          Take no action that would cause the conditions upon which the obligations of the parties to
effect the transaction contemplated by this Agreement not to be fulfilled including, without
limitation, taking or causing to be taken any action that would cause the representations and
warranties made by the Alesco CDO in this Agreement not to be true and correct in all material
respects as of the Closing Date.

          5.2 Certain Acts.

          Use commercially reasonable efforts (including, without limitation, executing required
documents and paying any related fees and expenses required by contract or otherwise) to cause to
be fulfilled the conditions precedent to the Company’s obligations to consummate the transaction
contemplated by this Agreement that are dependent upon the actions of the Alesco CDO.

          5.3 Governmental Filings.

          Promptly make all governmental filings or other submissions, if any, which may be necessary in
order for the Alesco CDO to be able to consummate the transaction contemplated by this Agreement.

14

 

          5.4 No Shop; Standstill.

          Refrain from taking, directly or indirectly, any action to encourage, initiate, solicit or
continue any discussions or negotiations with, or any other offers from, any other person or entity
concerning the sale of the TruPS.

     6. Covenants of Company.

          In addition to other obligations contained in this Agreement, between the date of this
Agreement and the Closing Date, unless specifically waived, in writing, by the Alesco CDO, the
Company shall:

          6.1 Cooperation.

          Take no action that would cause the conditions upon which the obligations of the parties to
effect the transaction contemplated by this Agreement not to be fulfilled including, without
limitation, taking or causing to be taken any action that would cause the representations and
warranties made by the Company in this Agreement not to be true and correct in all material
respects as of the Closing.

          6.2 Certain Acts.

          Use commercially reasonable efforts (including, without limitation, executing required
documents and paying any related fees and expenses required by contract or otherwise) to cause to
be fulfilled the conditions precedent to the Alesco CDO’s obligations to consummate the transaction
contemplated by this Agreement that are dependent upon the actions of the Company.

          6.3 Registration Rights.

          The Company agrees, at its own expense, within sixty (60) days of the Closing Date and within
sixty (60) days of the exercise of any warrant referred to herein, to prepare and file a
registration statement with the Securities and Exchange Commission with respect to the

15

 

resale of
any common stock or warrant issued hereunder, and thereafter use its best efforts to cause the
registration statement to become effective as soon as reasonably practicable.

          6.4 Governmental Filings.

          Promptly make all governmental filings or other submissions, if any, which may be necessary in
order for the Company to be able to consummate the transaction contemplated by this Agreement.

     7. Conditions Precedent to the Obligations of the Alesco CDO.

          Unless each of the following conditions are satisfied or waived, in writing, by the Alesco
CDO, the Alesco CDO shall not be obligated to effect the transaction contemplated by this
Agreement:

          7.1 Representations and Warranties.

          The representations and warranties of the Company contained in this Agreement shall be true
and complete in all material respects as of the date of this Agreement and as of the Closing Date
(as if each were made at such time), and Alesco CDO shall have received a certificate signed by an
authorized officer of the Company to that effect.

          7.2 Performance.

          Each of the agreements, obligations, conditions and covenants to be performed or complied with
by the Company at or prior to the Closing Date pursuant to the terms of this Agreement shall have
been fully performed or complied with on or before the Closing Date, including, without limitation,
each of the deliveries to be made by Company pursuant to Section 9.3.

          7.3 Absence of Litigation.

          There shall be no pending or threatened claim, action, litigation, suit or other proceeding,
either judicial or administrative, against the Alesco CDO, or with respect to the

16

 

Company, for the
purpose of enjoining or preventing the consummation of this Agreement or otherwise claiming that
this Agreement or its consummation is improper or adversely affecting or which would adversely
affect the benefit to Alesco CDO of the transaction contemplated by this Agreement.

          7.4 Consents.

          All consents, approvals, permits, estoppel certificates and/or waivers from governmental
authorities and all other persons or entities necessary to effectuate the transaction contemplated
by this Agreement and/or in the case of governmental regulations all applicable time periods shall
have expired or been terminated.

     8. Conditions Precedent to Obligations of Company.

          Unless each of the following conditions are satisfied or waived, in writing, by the Company,
the Company shall not be obligated to effect the transaction contemplated by this Agreement:

          8.1 Representations and Warranties.

          The representations and warranties of the Alesco CDO and the Manager contained in this
Agreement shall be true and complete in all material respects as of the date of
this Agreement and as of the Closing Date (as if each were made at such time), and the Company
shall have received a certificate signed by an authorized officer of the Alesco CDO and the Manager
to that effect.

          8.2 Performance.

          Each of the agreements, obligations, conditions and covenants to be performed or complied with
by the Alesco CDO, at or prior to the Closing, pursuant to the terms of this Agreement shall have
been fully performed or complied with on or before the Closing Date,

17

 

including, without limitation,
each of the deliveries to be made by the Alesco CDO pursuant to Section 9.2.

          8.3 Absence of Litigation.

          There shall be no pending or threatened claim, action, litigation, suit or other proceeding,
either judicial or administrative, against the Company or the Alesco CDO for the purpose of
enjoining or preventing the consummation of this Agreement or otherwise claiming that this
Agreement or its consummation is improper or which would adversely affect the benefit to the
Company of the transaction contemplated by this Agreement.

          8.4 Consents.

          All consents, approvals, permits, estoppel certificates and/or waivers from governmental
authorities and all other persons or entities necessary to effectuate the transaction contemplated
by this Agreement and/or in the case of governmental regulations all applicable time periods shall
have expired or been terminated.

     9. Closing and Post-Closing Covenants.

          9.1 Time and Place.

          The closing under this Agreement (the “Closing”) shall take place at 10:00 a.m. on September
3, 2009 (the “Closing Date”), at the offices of Krugliak, Wilkins, Griffiths & Dougherty Co.,
L.P.A. in Canton, Ohio, or such other time and/or place as may be agreed to by
the Company and the Alesco CDO. If all of the conditions set forth in Sections 7 and 8 are
not satisfied by such date, subject to extension as provided in this Agreement, the Company or the
Alesco CDO, as the case may be in connection with the applicable condition, shall have the right,
but not the obligation, to postpone the Closing from time to time, but not beyond an additional
thirty (30) days in the aggregate. Notwithstanding the foregoing, if the failure to

18

 

satisfy a
condition is a breach of this Agreement, exercise of an option provided in this Section 9.1 shall
not constitute a waiver of such breach or of the right to seek damages for such breach.

          9.2 Obligations of the Alesco CDO.

          At the Closing, the Alesco CDO shall deliver to Company:

               9.2.1 The officer’s certificate dated as of the Closing Date, as described in Section 8.1;

               9.2.2 The TruPS;

               9.2.3 A certified copy of the resolutions of the Board of Directors of the Alesco CDO, all of
which are authorizing the execution, delivery and performance of the transaction contemplated by
this Agreement;

               9.2.4 A copy of the Collateral Management Agreement;

               9.2.5 An executed copy of the Joint Cancellation Direction and Release, in form satisfactory
to the Company and its counsel;

               9.2.6 All required consents, approvals, permits, estoppel certificates and/or waivers as
required by Section 8.4, if any;

               9.2.7 Such other certificates, instruments and documents of transfer, if any, as may be
necessary to consummate the transaction contemplated by this Agreement.

          9.3 Obligations of the Company.

          At the Closing, the Company shall deliver to the Alesco CDO:

               9.3.1 The Exchange Price by wire transfer of immediately available funds pursuant to the wire
instructions set forth on Exhibit C;

               9.3.2 The Common Stock;

               9.3.3 The officer’s certificate dated as of the Closing Date as described in Section 7.1;

19

 

               9.3.4 A certified copy of the resolutions of the Board of Directors of the Company authorizing
the execution, delivery and performance of, and the transaction contemplated by, this Agreement;

               9.3.5 The Warrant, as described and set forth in Section 2.1(c);

               9.3.6 The Warrant, as described and set forth in Section 2.1(d);

               9.3.7 A copy of the Joint Direction and Release Agreement; and

               9.3.8 All required consents, approvals, permits, estoppel certificates and/or waivers as
required by Section 7.4, if any;

               9.3.9 Such other certificates, instruments and documents of transfer if any, as may be
necessary to consummate the transaction contemplated by this Agreement.

     10. Indemnification.

          10.1 Indemnification by Alesco CDO.

          From and after the Closing Date, the Alesco CDO shall indemnify, defend and hold harmless
Company and its stockholders, directors, officers, employees and agents and their successors and
assigns against any loss, claim, damage, cost, obligation, liability, penalty and expense,
including all legal and other expenses reasonably incurred in connection with investigating or
defending against any such loss, claim, damage, cost, obligation, liability, penalty or expense or
action in respect of such matters (collectively referred to as “Section 10 Damages”), occasioned
by, arising out of or resulting from any breach or default of any representation or warranty by, or
covenant of, the Alesco CDO or the Manager contained in this Agreement or any other agreement
provided for in this Agreement. Indemnification under this Section 10 shall constitute the
Company’s exclusive remedy for any breach or default of any
representation or warranty by, or covenant of, the Alesco CDO or the Manager contained in this
Agreement or any other agreement provided for in this Agreement, except in cases of fraud. The
Company may pursue other remedies in addition to indemnification for fraud.

          10.2 Indemnification by Company.

          From and after the Closing, Company shall indemnify, defend and hold harmless the Alesco CDO
and its agents, successors and assigns against any Section 10 Damages

20

 

occasioned by, arising out of
or resulting from any breach or default of any representation or warranty by, or covenant of
Company contained in this Agreement or any other agreement provided for in this Agreement.
Indemnification under this Section 10 shall constitute the Alesco CDO’s exclusive remedy for any
breach or default of any representation or warranty by, or covenant of Company contained in this
Agreement or any other agreement provided for in this Agreement, except in cases of fraud. The
Alesco CDO may pursue other remedies in addition to indemnification for fraud.

          10.3 Notice of Indemnification.

          Upon receipt by an indemnified party of notice of the commencement against it of any action
involving a claim, such indemnified party, if a claim in respect of such action is to be made by it
against any indemnifying party under this Section 10, shall promptly notify in writing the
indemnifying party of such commencement. In case any such action is brought against any
indemnified party, and it notifies an indemnifying party of such commencement, the indemnifying
party will be entitled to participate in the defense and, to the extent that it may wish, jointly
with any other indemnifying party similarly notified, assume the defense of the action, with
counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying
party to such indemnified party of its election to assume the defense, the indemnifying party will
not be liable to such indemnified party under this Section 10 for any legal or other expenses
subsequently incurred by such indemnified party in connection with the defense other than
reasonable costs of investigation. Any such indemnifying party shall not be
liable to any such indemnified party on account of any settlement of any claim or action effected
without the consent of such indemnifying party unless the indemnifying party had determined not to
assume the defense of the action. The indemnifying party will not settle or compromise

21

 

any claim or
action without the written consent of the indemnified party (which consent shall not be
unreasonably withheld)

          10.4 Basket.

          Except as otherwise provided in this Agreement, neither the Alesco CDO, on the one hand, nor
Company, on the other hand, shall have any liability for indemnification pursuant to Section 10
unless the total Section 10 Damages for which the indemnifying party would otherwise be liable
exceeds $50,000 in the aggregate, in which case the liability for indemnification shall include
such $50,000. The maximum amount of indemnification claims for which the Alesco CDO shall be
liable in the aggregate shall not exceed the Exchange Price as set forth in Section 2.1.

     11. Termination.

          This Agreement shall be terminated and the transaction contemplated by this Agreement
abandoned at any time prior to the Closing:

          11.1 By mutual written consent of the Company and the Alesco CDO.

          11.2 By Company upon written notice to the Alesco CDO, if the Alesco CDO has violated or
breached any representation, warranty or covenant contained in this Agreement or any agreement
contemplated by this Agreement; provided that the Company shall have given the breaching party
thirty (30) days’ advance written notice setting forth the basis on which the Company is exercising
its right to terminate and such violation or breach is not cured within such thirty (30) days.

          11.3 By the Alesco CDO upon written notice to the Company, if the Company has violated or
breached any representation, warranty or covenant contained in this Agreement or
any agreement contemplated by this Agreement; provided that the Alesco CDO shall have given
the Company thirty (30) days’ advance written notice setting forth the basis on which the Alesco

22

 

CDO is exercising its right to terminate and such violation or breach is not cured within such
thirty (30) days.

          Termination by the Company or the Alesco CDO pursuant to Sections 11.2 or 11.3, respectively,
shall not constitute a waiver of the breach affording such right of termination or of the right to
seek damages for such breach.

          11.4 Automatically if the Closing has not occurred on or before October 1, 2009.

     12. Release. As a part of the consideration of this Agreement, the Alesco CDO and for
the personal representatives, successors, and assigns of the Alesco CDO, does hereby remise,
release, and forever discharge the Company and the officers, employees, directors, and stockholders
thereof, of and from all manner of actions, whether intentional or negligent, causes and causes of
action, suits, debts, sums of money, account reckonings, bonds, bills, specialties, covenants,
controversies, agreements, promises, variances, trespasses, damages, judgments, executions, claims,
and demands, whatsoever, at law or in equity, and particularly, in regard to any and all claims
relating to the TruPS and any and all transactions in relation thereto other than the transaction
entered into pursuant to this Agreement (including without limitation any guaranties of the same
and without limitation any claim to dividends deferred and not paid under the TruPS), which Alesco
CDO or Alesco CDO’s personal representatives, successors, assigns, and agents ever had, now have,
or may have in the future, for, upon or by reason of any matter, cause, or thing, whatsoever
relating to the TruPS and any transactions in relation thereto other than the transaction entered
into pursuant to this Agreement (including without limitation any guaranties of the same and
without limitation any claim to dividends deferred and not paid under the TruPS).

23

 

     13. Specific Performance. Notwithstanding anything to the contrary contained herein,
if any party to this Agreement fails to fulfill any of its obligation pursuant to this Agreement,
or if any of the covenants or representations set forth in this Agreement are not true and correct
pursuant to the terms of this Agreement, each party hereto agrees that the other party would suffer
irreparable harm from any such breach. In the event of an alleged or threatened breach by any party
of any of the provisions of this Agreement, the aggrieved party may, in addition to all other
rights and remedies existing in its favor, apply to any court of competent jurisdiction for
specific performance and/or injunctive relief in order to enforce or prevent any violations of the
provisions of this Agreement.

     14. Miscellaneous.

          14.1 Notices.

          All notices, demands or requests provided for or permitted to be given pursuant to this
Agreement must be in writing and shall be delivered or sent, with the copies indicated, by personal
delivery, telecopy (with confirmation and additional copy sent by overnight delivery service) or
overnight delivery service (by a reputable international carrier) to the parties as follows (or at
such other address as a party may specify by notice given pursuant to this Section):

	 	 	 
	To Alesco CDO:

	 	ALESCO PREFERRED FUNDING IV, LTD.
	 

	 	c/o Cohen & Company Financial Management, LLC
	 

	 	2929 Arch Street, 17th Floor
	 

	 	Philadelphia, PA 19104-2870
	 

	 	Attn: Samuel Hillier, Director
	 

	 	Fax: (215) 701-8282
	 

	 	Email: shillier@cohenandcompany.com

24

 

	 	 	 
	 
	 	 
	With a Copy to:

	 	DECHERT LLP
	 

	 	2929 Arch Street
	 

	 	Philadelphia, PA 19104
	 

	 	Attn: Ralph R. Mazzeo, Esq.
	 

	 	Fax: (215) 994-2222
	 

	 	Email: ralph.mazzeo@dechert.com
	 
	 	 
	To Manager:

	 	COHEN & COMPANY FINANCIAL MANAGEMENT, LLC
	 

	 	2929 Arch Street, 17th Floor
	 

	 	Philadelphia, PA 19104-2870
	 

	 	Attn: Samuel Hillier, Director
	 

	 	Fax: (215) 701-8282
	 

	 	Email: shillier@cohenandcompany.com
	 
	 	 
	With a Copy to:

	 	DECHERT LLP
	 

	 	2929 Arch Street
	 

	 	Philadelphia, PA 19104
	 

	 	Attn: Ralph R. Mazzeo, Esq.
	 

	 	Fax: (215) 994-2222
	 

	 	Email: ralph.mazzeo @dechert.com
	 
	 	 
	To Company:

	 	PVF CAPITAL CORP.
	 

	 	30000 Aurora Road
	 

	 	Solon, Ohio 44139
	 

	 	Attn: Chief Executive Officer
	 

	 	Fax: (440) 914-3916

25

 

	 	 	 
	 
	 	 
	With a copy to:

	 	Krugliak, Wilkins, Griffiths
	 

	 	& Dougherty Co., L.P.A.
	 

	 	4775 Munson St. N.W.
	 

	 	P.O. Box 36963
	 

	 	Canton, Ohio 44735-6963
	 

	 	Attn: Randall C. Hunt,
	 

	 	Fax: (330) 497-4020
	 

	 	Email: rchunt@kwgd.com

All notices shall be deemed given and received one business day after their delivery to the
addresses for the respective party(ies), with the copies indicated, as provided in this Section
12.1.

          14.2 Entire Agreement.

          This Agreement, the documents which are Exhibits and Schedules to this Agreement and any other
contemporaneous written agreements entered into by the parties contain the sole and entire binding
agreement among and representations made by the parties to each other and supersede any and all
other prior written or oral agreements and representations among them.

          14.3 Amendment.

          No amendment or modification of this Agreement shall be valid unless, in writing, and duly
executed by the parties affected by the amendment or modification.

          14.4 Binding Effect.

          This Agreement shall be binding upon and inure to the benefit of the parties and their
respective representatives, heirs, successors and permitted assigns.

26

 

          14.5 Waiver.

          Waiver by any party of any breach of any provision of this Agreement shall not be considered
as or constitute a continuing waiver or a waiver of any other breach of the same or any other
provision of this Agreement.

          14.6 Captions.

          The captions contained in this Agreement are inserted only as a matter of convenience or
reference and in no way define, limit, extend or describe the scope of this Agreement or the intent
of any of its provisions.

          14.7 Construction.

          In the construction of this Agreement, whether or not so expressed, words used in the singular
or in the plural, respectively, include both the plural and the singular and the masculine,
feminine and neuter genders include all other genders. Since all parties have engaged in the
drafting of this Agreement, no presumption of construction against any party shall apply.

          14.8 Sections and Schedules.

          All references contained in this Agreement to Sections and/or Schedules shall be deemed to be
references to Sections of and Schedules and Exhibits attached to this Agreement, except to the
extent that any such reference specifically refers to another document. All references to Sections
shall be deemed to also refer to all subsections of such Sections, if any. The definitions of terms
defined in this Agreement shall apply to the Schedules.

          14.9 Severability.

          In the event that any portion of this Agreement is illegal or unenforceable, it shall affect
no other provisions of this Agreement, and the remainder of this Agreement shall be valid and
enforceable in accordance with its terms.

27

 

          14.10 Absence of Third-Party Beneficiaries.

          Nothing in this Agreement, express or implied, is intended to (a) confer upon any person or
entity other than the parties to this Agreement, any rights or remedies under or by reason of this
Agreement as a third-party beneficiary or otherwise; or (b) authorize anyone not a party to this
Agreement to maintain an action or institute an arbitration proceeding pursuant to or based upon
this Agreement.

          14.11 Business Day.

          As used in this Agreement, the term “business day” means any day other than a Saturday, Sunday
or legal or bank holiday in the City of New York, NY (the “City”). If any time period set forth in
this Agreement expires on other than a business day in the City, such period shall be extended to
and through the next succeeding business day in the City.

          14.12 Assignment.

          Neither this Agreement nor any rights under this Agreement may be assigned by any party
without the written consent of all other parties.

          14.13 Other Documents.

          The parties shall take all such actions and execute all such documents which may be necessary
to carry out the purposes of this Agreement, whether or not specifically provided for in this
Agreement.

          14.14 Governing Law.

          This Agreement and the interpretation of its terms shall be governed by the laws of the State
of New York, without application of conflicts of law principles.

          14.15 Attorneys Fees.

          Company shall pay the fees and expenses of the Alesco CDO’s legal counsel up to the sum of Ten
Thousand Dollars ($10,000.00), and Company shall pay its attorneys’ fees and

28

 

expenses for the
negotiation and preparation of this Agreement, the Exhibits and Schedules and the other agreements
contemplated by this Agreement.

          14.16 Public Disclosure.

          No party to this Agreement shall make any public disclosure or publicity release pertaining to
the existence of the subject matter contained in this Agreement without notifying and consulting
with the other parties and upon approval of a joint press release; provided, however, that
notwithstanding the foregoing, each party shall be permitted, after notice to the
other parties, to make such disclosures to the public or to governmental agencies as its
counsel shall deem necessary to maintain compliance with, and to prevent violation of, applicable
laws, federal, state and local, domestic and foreign.

          14.17 Counterparts.

          This Agreement may be executed and delivered in two or more counterparts, each of which shall
be deemed to be an original and all of which, taken together, shall be deemed to be one agreement.

[The Remainder of the Page is Intentionally Left Blank]

29

 

          The parties have executed this Agreement as of the date set forth above.

	 	 	 	 	 
	 	ALESCO PREFERRED FUNDING IV, LTD.

By: COHEN & COMPANY FINANCIAL MANAGEMENT, LLC, solely in its capacity as Manager

 	 
	 	By:  	/s/ Samuel Hillier 	 
	 	 	Name:  	Samuel Hillier 	 
	 	 	Title:  	Director 	 
	 
	 	PVF CAPITAL CORP.,

 	 
	 	By:  	/s/ Marty E. Adams 	 
	 	 	Name:  	Marty E. Adams 	 
	 	 	Title:  	Interim CEO 	 
	 
	 	COHEN & COMPANY FINANCIAL MANAGEMENT, LLC, solely as to Sections 3.2 and 3.5

 	 
	 	By:  	/s/ Samuel Hillier 	 
	 	 	Name:  	Samuel Hillier 	 
	 	 	Title:  	Director 	 

30

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}]]